Abstract
The study of clinical and demographic characteristics related to virus control and disease progression in patients who spontaneously control HIV vireamia (HIV-controllers) is of major interest. A particular cause of HIV control has not been found and the scenario could be partially explained by special homeostatic and immunological features. In this study, CD57+CD28- phenotype, T-cell activation and levels of proliferating T-cells in elite-controllers were studied in relation to spontaneous virus control. In HIV-controllers, 9% were AIDS-diagnosed and there was a high proportion of women. In elite-controllers, high T-cell CD57+CD28- phenotype and activation levels were found and, interestingly, there was a low proliferation of total and naive T-cells and a high proliferation of the CD4+ TEMRA subset. Low T-cell proliferation and preferential expansion of terminally differentiated effector T-cell subsets could be an important factor for virus control in elite-controllers.
Keywords: HIV, elite-controllers, immunosenescence, activation, CD57+, proliferation, TEMRA
Current HIV Research
Title: High Levels of CD57+CD28- T-Cells, Low T-Cell Proliferation and Preferential Expansion of Terminally Differentiated CD4+ T-Cells in HIVElite Controllers
Volume: 8 Issue: 6
Author(s): Ezequiel Ruiz-Mateos, Sara Ferrando-Martinez, Kawthar Machmach, Pompeyo Viciana, Yolanda M. Pacheco, Nieves Nogales, Miguel Genebat and Manuel Leal
Affiliation:
Keywords: HIV, elite-controllers, immunosenescence, activation, CD57+, proliferation, TEMRA
Abstract: The study of clinical and demographic characteristics related to virus control and disease progression in patients who spontaneously control HIV vireamia (HIV-controllers) is of major interest. A particular cause of HIV control has not been found and the scenario could be partially explained by special homeostatic and immunological features. In this study, CD57+CD28- phenotype, T-cell activation and levels of proliferating T-cells in elite-controllers were studied in relation to spontaneous virus control. In HIV-controllers, 9% were AIDS-diagnosed and there was a high proportion of women. In elite-controllers, high T-cell CD57+CD28- phenotype and activation levels were found and, interestingly, there was a low proliferation of total and naive T-cells and a high proliferation of the CD4+ TEMRA subset. Low T-cell proliferation and preferential expansion of terminally differentiated effector T-cell subsets could be an important factor for virus control in elite-controllers.
Export Options
About this article
Cite this article as:
Ruiz-Mateos Ezequiel, Ferrando-Martinez Sara, Machmach Kawthar, Viciana Pompeyo, Pacheco M. Yolanda, Nogales Nieves, Genebat Miguel and Leal Manuel, High Levels of CD57+CD28- T-Cells, Low T-Cell Proliferation and Preferential Expansion of Terminally Differentiated CD4+ T-Cells in HIVElite Controllers, Current HIV Research 2010; 8 (6) . https://dx.doi.org/10.2174/157016210793499268
DOI https://dx.doi.org/10.2174/157016210793499268 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Health Benefits of Manuka Honey as an Essential Constituent for Tissue Regeneration
Current Drug Metabolism Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases
Current Pharmaceutical Design Operational Issues and Barriers to Implementation of Prevention of Mother-to-Child Transmission of HIV (PMTCT) Interventions in Sub- Saharan Africa
Current HIV Research An Experience with Delamanid in an XDR TB Case – Case Report
Infectious Disorders - Drug Targets Functional Gene Discovery Using RNA Interference-Based Genomic Screens to Combat Pathogen Infection
Current Drug Discovery Technologies Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds Immunopotentiation for Bacterial Biodefense
Current Topics in Medicinal Chemistry Four Types of Novel Potential Malate Synthase Inhibitors from Virtual Screening
Current Enzyme Inhibition Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Revision and Implementation of “Clinical Guideline for Tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran
Infectious Disorders - Drug Targets Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
Current Drug Targets Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Current Respiratory Medicine Reviews Inflammation in Fish As Seen from A Morphological Point of View with Special Reference to the Vascular Compartment
Current Pharmaceutical Design Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Novel, Unifying Phagomimetic Mechanism of Vancomycin Therapeutic Action and Toxicity: Polyphenol, Electron Transfer and Reactive Oxygen Species
Anti-Infective Agents in Medicinal Chemistry Molecular Dynamics Simulations of Protein Targets Identified in Mycobacterium tuberculosis
Current Medicinal Chemistry Self-assembled Antibiotic Nanoparticles Against Intracellular Bacteria
Drug Delivery Letters Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry Thymidylate Kinase: An Old Topic Brings New Perspectives
Current Medicinal Chemistry Recent Developments of Thalidomide Derivatives Possessing Anti-Inflammatory Activity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry